AI-Powered Diagnostic Solutions
AI solutions built to improve every step of the patient journey
Company profile
Company profile
Siemens Healthineers USA is a leading medical technology company committed to revolutionizing healthcare delivery across America. With over 17,000 employees nationwide and 18 business centers, the company provides comprehensive solutions in diagnostic and therapeutic imaging, laboratory diagnostics, molecular medicine, digital health, and enterprise services. Their portfolio includes advanced medical imaging systems (CT, MRI, PET/CT, ultrasound, interventional radiology), laboratory diagnostics platforms, point-of-care testing devices, and healthcare IT solutions including AI-powered clinical decision support tools. The company invests more than $900 million annually in U.S.-based research and development, demonstrating a long-standing commitment to innovation and American healthcare infrastructure. Siemens Healthineers serves diverse healthcare providers from rural to urban communities, focusing on making care more precise, personal, and connected. Their solutions span multiple clinical specialties including cardiology, oncology, neurology, women's health, and surgery, with particular emphasis on expanding precision medicine, transforming care delivery, improving patient experience, and digitalizing healthcare. The company's technology portfolio includes the world's first photon-counting CT (NAEOTOM Alpha), the Biograph family of PET/CT scanners (celebrating 25 years of innovation), AI-powered mobile C-arms, and the Atellica laboratory diagnostics solution. Through value partnerships, education programs, and workforce development initiatives, Siemens Healthineers aims to empower healthcare providers to deliver better patient outcomes while addressing critical challenges like staff shortages and operational efficiency.
Company description Siemens Medical Solutions, Inc official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas · Embedded · Hybrid · On Premise deployment with recorded integration context.
Company milestones
Launch of NAEOTOM Alpha photon-counting CT (world's first fleet), introduction of new Artis Family AI-powered interventional systems, 25th anniversary of Biograph PET/CT platform, expansion of Mobile Stroke Units program
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI solutions built to improve every step of the patient journey
AI-powered medical imaging analysis and autocontouring solution
AI-powered interventional imaging systems
Comprehensive laboratory diagnostics automation and testing solutions
Curated healthcare data repository with 2.3 billion images and clinical records
Leading PET/CT imaging for 25 years, combining PET and CT in one device
Point-of-care testing for critical care and chronic disease monitoring
Digital health platform for personalized citizen care
Comprehensive digital health and IT infrastructure solutions
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Magnetic resonance in medicine · Jan 1, 2026
Large scale comparison of maximum likelihood scatter scaling and tail-fitted scatter scaling in LAFOV PET/CT.EJNMMI physics · Sep 29, 2025
Enhancing the predictive capability of magnetic resonance imaging using medical data-supervised cardiovascular flow simulations: A case study for analyzing patient-specific flow in the human aorta.Computers in biology and medicine · May 1, 2025
Patient-specific prediction of arterial wall elasticity using medical image-informed in-silico simulations.Computers in biology and medicine · Apr 1, 2025
Performance of respiratory gated 4D flow MRI with adaptive k-space reordering in healthy controls and aortic dissection: reproducibility and agreement with 2D phase contrast MRI.The international journal of cardiovascular imaging · Feb 1, 2025
Improving cone-beam computed tomography image quality for transarterial therapy of liver malignancies: Evaluation of a motion correction algorithm with and without automated bone removal.Journal of clinical imaging science · Jan 1, 2025
Clinical validation
NCT06948162 · Sponsor · RECRUITING
Regulatory
K253574 · 510k · Mar 20, 2026
MI View&GOK254016 · 510k · Feb 10, 2026
ACUSON Sequoia Diagnostic Ultrasound System; ACUSON Sequoia Select Diagnostic Ultrasound System; ACUSON Origin Diagnostic Ultrasound System; ACUSON Origin ICE Diagnostic Ultrasound SystemK251481 · 510k · Aug 20, 2025
YSIO X.preeK250738 · 510k · Jul 31, 2025
LUMINOS Q.namix T; LUMINOS Q.namix RK250660 · 510k · Jul 14, 2025
syngo.via MI Workflows; Scenium; syngo MBFK251528 · 510k · Jul 3, 2025
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Mobile Stroke Units with CT imaging and telemedicine
Automation in surgical workflows including robotic-assisted surgery
Workflow automation and AI-powered clinical decision support
Patient engagement through online symptom reporting to optimize and personalize cancer care, incorporating timely first-hand information from patients
Leveraging remote services and digital support to extend cancer care across vast distances in China
Improved access to cancer care and patient outcomes despite workforce shortages
Empowering workforce with human-factor engineering to achieve operational excellence
Building a human-centered workplace that improves efficiency and patient care
Reducing contouring effort and variability in radiation therapy planning through AI-based autocontouring for organs-of-interest
Providing citizens of São Paulo with access to personalized care through digital health platform powered by eHealth Solutions
Addressing workforce gaps through an Imaging Apprenticeship Program to train new radiology and MRI technologists
Successfully training and retaining skilled radiology professionals to address staff shortages
Implementing workforce solutions and operational excellence initiatives
Improved operational efficiency and staff well-being
Implementing automation in surgical workflows including robotic-assisted surgery to improve efficiency
Reduced errors and streamlined operations through surgical automation
Automating medical imaging procedures through AI-driven exam-protocol selection to streamline workflows and enable personalized diagnostics
Implementing autocontouring solutions in radiation therapy to improve consistency and reduce variability in treatment planning
>95% of autocontouring results are clinically usable or require minor edits
05 · Leadership
Leadership profiles and professional links from the current Company record.
Dorin Comaniciu
Senior VP, Artificial Intelligence and Digital Innovation
06 · Company updates
Recent articles published on Siemens Medical Solutions, Inc's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.